FindTrial
Sign In

An exploratory study to identify the factors related to recurrence of Generalized Pustular Psoriasis (GPP) flare in adult patients with GPP in Japan

An exploratory study to identify the factors related to recurrence of Generalized Pustular Psoriasis (GPP) flare in adult patients with GPP in Japan - An exploratory study to identify the factors related to recurrence of GPP flare

Status
Active, not recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000052793
Enrollment
205
Registered
2023-11-22
Start date
2023-11-22
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Generalized Pustular Psoriasis (GPP)

Interventions

None listed

Sponsors

Nippon Boehringer Ingelheim Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: -Patients who have been diagnosed with von Zumbusch type of GPP -Patients who experienced a GPP flare at baseline confirmed by the Data Review Committee -Patients whose data were properly obtained for this study in accordance with the local regulations

Exclusion criteria

Exclusion criteria: -Patients who have been diagnosed with paediatric GPP, impetigo herpetiformis, or other categories of GPP -Patients who have been diagnosed with unknown disease categories of GPP

Design outcomes

Primary

MeasureTime frame
Outcome: Recurrence of GPP flares in patients who experienced a GPP flare at baseline Time Frame: From the date of onset of the baseline GPP flare to the date of recurrence of a GPP flare or to the end of the follow-up Event: Recurrence of GPP flares confirmed by the Data Review Committee—

Countries

Japan

Contacts

Public ContactMorihisa Saitoh

Nippon Boehringer Ingelheim Co., Ltd. Medical Aff airs Group, Immunology Medicine Dept., Clinical Development Medical Affairs

morihisa.saitoh@boehringer-ingelheim.com03-6417-2200

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026